195
Views
80
CrossRef citations to date
0
Altmetric
Article

Post‐irradiation approaches to treatment of radiation injuries in the context of radiological terrorism and radiation accidents: a review

Pages 3-10 | Received 17 Sep 2003, Accepted 15 Oct 2003, Published online: 03 Jul 2009

References

  • AYGENC, E., CELIKKANAT, S., BILGILI, H., AKSARAY, F., ORHUN, S., KAymAxci, M. and OZDEM, C., 2001, Pentoxifylline effects on acute and late complications after radiotherapy in rabbit. Otolaryngology—Head and Neck Surgery, 124, 669–673.
  • BAUCHINGER, M., ScHmio, E. and BRASELMANN, H., 2001, Time-course of translocation and clicentric frequencies in a radiation accident case. International Journal of Radiation Biology, 77, 553–557.
  • BELKACEMI, Y., LABOPEN, M., VERNANT, J. P., PRENTICE, H. G., TICHELLI, A., SCHATTENBERG, A., BOOGAERTS, M. A., ERNST, P., VOLPE, A. D., GOLDSTONE, A. H., JouET, J. P., VERDONCK, L. F., LOCASCIULLI, A., Rio, B., OZSAHIN, M. and GORIN, N. C., 1998, Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation. International Journal of Radiation Oncology, Biology and Physics, 41, 659–668.
  • BLAKELY, W. F., BROOKS, A. L., LoFrs, R. S., VANDER SCHANS, G. P. and VOISIN, P., 2002, Overview of low-level radiation exposure assessment: biodosimetry. Military Medicine, 167\(Suppl. 1), 20–24.
  • BLAKELY, W. F., MILLER, A. C., GRACE, M. B., MCLELAND, C. B., LUE, L., MUDERHWA, J. M., MINER, V. L. and PRASSANA, P. G. S., 2003, Radiation biodosimetry: applications for spaceflight. Advances in Space Research, 31, 1487–1493.
  • Boss, L. P., 1997, Epidemic hysteria: a review of the published literature. Epidemiologic Reviews, 19, 233–243.
  • BOULAD, F., SANDS, S. and SKLAR, C., 1998, Late complications after bone marrow transplantation in children and adolescents. Current Problems in Pediatrics, 28, 277–297.
  • CLARK," G., HANSEN," A., HERTZ, M. I., PARKMAN, R., JENSEN, L. and PEAVY, H. H., 1993, NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. American Review of Respiratory Disease, 147, 1601–1606.
  • Crirr, R. A., BIANCO, J. A., APPELBAUM, F. R., BUCKNER, C. D., SINGER," W., BAKKE, L., BENSINGER, W. I., BOWDEN, R. A., MCDONALD, G. B., SCHUBERT, M., SHIELDS, A. F., SLATTERY, J. T., STORB, R., FISHER, L. D., MORI, M., THOMAS, E. D. and HANSEN, J. A., 1993, A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation. Blood, 82, 2025–2030.
  • COHEN, E. P., 2000, Radiation nephropathy after bone marrow transplantation. Kidney International, 58, 903–918.
  • COHEN, E. P., FISH, B. L. and MOULDER, J. E., 2002, The renin-angiotensin system in experimental radiation nephropathy. Journal of Laboratory and Clinical Medicine, 139, 251–257.
  • COHEN, E. P., HUSSAIN, S. and MOULDER, J. E., 2003, Successful treatment of radiation nephropathy with angiotensin II blockade. International Journal of Radiation Oncology, Biology and Physics, 55, 190–193.
  • COHEN, E. P. and LAWTON, C. A., 1998, Pathogenesis, prevention and management of radiation nephropathy. In J. S. Tobias and P. R. M. Thomas (eds), Current Radiation Oncology (New York: Oxford University Press), pp. 94–109.
  • COLEMAN, C. N., BLAKELY, W. F., FIKE, J. R., MAcVrrnE, T. J., METTING, N. F., MITCHELL," B., MOULDER," E., PRESTON, R. J., SEED, T. M., STONE, H. B., TOFILON, P. J. and WONG, R. S. L., 2003, Molecular and cellular biology of moderate-dose (1–10 Gy) radiation and potential mechanisms of radiation protection: report of a work-shop at Bethesda, Maryland, December 17–18, 2001. Radiation Research, 159, 812–834.
  • CONFER, D. L., 2002, Donor selection and management of hematopoietic cell transplantation. In R. C. Ricks, M. E. Berger and F. M. O'Hara (eds), The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims (Boca Raton: Parthenon) pp. 109–116.
  • DATrA, P. K., MOULDER, J. E., FISH, B. L., COHEN, E. P. and LIANOS, E. A., 1999, TGF-$1 production in radiation nephropathy: role of angiotensin II. International Journal of Radiation Biology, 75, 473–479.
  • DELANIAN, S., BALLA-MEKIAS, S. and LEFAIX, J. L., 1999, Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. Journal of Clinical Oncology, 17, 3283–3290.
  • DORR, W., SPEKL, K. and FARRELL, C. L., 2002, Amelioration of acute oral mucositis by keratinocyte growth factor: fractionated irradiation. International Journal of Radiation Oncology, Biology and Physics, 54, 245–251.
  • DUNBAR, C. E., TAKATOKU, M. and DONAHUE, R. E., 2001, The impact of ex vivo cytokine stimulation on engraftment of primitive hematopoietic cells in a non-human primate model. Annals of the New York Academy of Sciences, 938, 236–245.
  • FASANO, A., 2002, Pathophysiology and management of radiation injury to the gastrointestinal tract. In R. C. Ricks, M. E. Berger and F. M. O'Hara (eds), The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims (Boca Raton: Parthenon), pp. 149–160.
  • FERRA, C., DE SANJOSE, S., LASTRA, C. F., MART!, F., MARIN°, E. L., SUREDA, A., BRUNET, S., GALLARDO, D., BERLANGA, J. J., GARCIA, J. and GRA&ENA, A., 1997, Pentoxifylline, cipro-floxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications. Bone Marrow Transplantation, 20, 1075–1080.Diu, J. R., GOBBEL, G. T., MARTON, L. J. and SErLHAN, T. M., 1996, Radiation brain injury is reduced by the polyamine inhibitor cc-difluoromethylornithine. Radiation Research, 138, 99–106.
  • FORNACE, A. J., AMUNDSON, S. A., Do, K. T., MELTZER, P., TRENT, J. and BrrTNER, M., 2002, Stress-gene induction by low-dose gamma irradiation. Military Medicine, 167\(Suppl. 1), 13–15.
  • FUTRAN, N. D., TRoTri, A. and GWEDE, C., 1997, Pentoxifylline in the treatment of radiation-related soft tissue injury: preliminary observations. Laryngoscope, 107, 391–395.
  • GEORGES, G. E. and STORB, R. F., 2002, Experimental and clinical experience with hematopoietic cell transplants. In R. C. Ricks, M. E. Berger and F. M. O'Hara (eds), The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims (Boca Raton: Parthenon), pp. 73–93.
  • GOANS, R. E., HOLLOWAY, E. C., BERGER, M. E. and Rims, R. C., 1997, Early dose assessment following severe radiation accidents. Health Physics, 72, 513–518.
  • GUNTER-SMITH, P. J. and DUBOIS, A., 1994, Treatment strategies for radiation-induced gastrointestinal injuries. Advances in the Biosciences, 94, 195–200.
  • Guo, H., SEDus-SHNA, J. A., EPPERLY, M. W., GRETroN, J. E., SHIN, D. M., BAR-SAGI, D., ARCHER, H. and GREENBERGER, J. S., 2003, Prevention of radiation-induced oral cavity mucositis by plasmid/liposome delivery of the human manganese superoxide clismutase (SOD2) transgene. Radiation Research, 159, 361–370.
  • GUSEV, I. A., GUSKOVA, A. K. and METTLER, F. A., 2001, Medical Management of Radiation Accidents (Boca Raton: CRC Press).
  • HANDE, M. P., AZIZOVA, T. V., GEARD, C. R., BURAK, L. E., MITCHELL, C. R., KHOKFIRYAKOV, V. F., VASILENKO, E. K. and BRENNER, D. J., 2003, Past exposure to densely ionizing radiation leaves a unique permanent signature in the genome. American Journal of Human Genetics, 72, 1162–1170.
  • HERODIN, F., BOURIN, P., MAYOL, J. F., LATAILLADE, J. J. and DROUET, M., 2003, Short-term injection of antiapoptotic cytokine combinations soon after lethal y-irradiation promotes survival. Blood, 101, 2609–2616.
  • HOPEWEIT, J. W., 1999, Modifying radiation injury to normal tissues: new opportunities. Frontiers of Radiation Therapy and Oncology, 32, 9–20.
  • KANDA, R., HAYATA, I. and LLOYD, D. C., 1999, Easy biodosimetry for high-dose radiation exposures using drug-induced, prematurely condensed chromosomes. International Journal of Radiation Biology, 75, 441–446.
  • KANG, C. M., PARK, K. P., SONG, J. E., JEOUNG, D. I., CHO, C. K., KIM, T. H., BAE, S., LEE, S. J. and LEE, Y. S., 2003, Possible biomarkers for ionizing radiation exposure in human peripheral blood lymphocytes. Radiation Research, 159, 312–319.
  • LAMPROGLOU, I., MAGDELENAT, H., BOISSERIE, G., BAILLET, F., MAYO, W., FESSI, H., PUISIEUX, F., PERDERAU, B., COLAS-LINHART, N. and DELATTRE, J. Y., 1998, An experimental model of acute encephalopathy after total body irradiation in the rat: effect of liposome-entrapped Cu/Zn superoxide dismutase. International Journal of Radiation Oncology, Biology and Physics, 42, 179–184.
  • LEBORGNE, J. H., LEBORGNE, F., ZUBIZARRETA, E.5 ORTEGA, B. and MEZZERA, J., 1998, Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomized trial. Radiotherapy and Oncology, 47, 145–148.
  • LEFAIX, J. L., DELANIAN, S., VOZENIN, M. C., LEPLAT, J. J.5 TRICAUD, Y. and MARTIN, M., 1999, Striking regression of sub-cutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and cc-tocopherol: an experimental study. International Journal of Radiation Oncology, Biology and Physics, 43, 839–847.
  • LEIPER, A. D., 1995, Late effects of total body irradiation. Archives of Disease in Childhood, 72, 382–385.
  • LEVI, M. A. and KELLY, H. C., 2002, Weapons of mass disruption. Scientific American, 287, 76–81.
  • LLOYD, D. C., EDWARDS, A. A., MOQUET, J. E. and GUERRERO-CARBAJAL, Y. C., 2000, The role of cytogenetics in early triage of radiation casualties. Applied Radiation and Isotopes, 52, 1107–1112.
  • MAcVrrHE, T. J. and FARESE, A. M., 2002, Cytokine-based treatment for acute radiation-induced myelosuppression: preclinical and clinical perspective. In R. C. Ricks, M. E. Berger and F. M. O'Hara (eds), The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims (Boca Raton: Parthenon), pp. 53–72.
  • MAEKAWA, K., 2002, Overview of medical care for highly exposed victims in the Tokaimura accident. In R. C. Ricks, M. E. Berger and F. M. O'Hara (eds), The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims (Boca Raton: Parthenon), pp. 313–318.
  • MAj, J. G., PARIS, F., Hpamovrrz-FRIEHmAN, A., VENKATRAMAN, E., KOLESNICK, R. and Fuxs, Z., 2003, Microvascular function regulates intestinal crypt response to radiation. Cancer Research, 63, 4338–4341.
  • MARQUES, L. J., ZHENG, L., POULAKIS, N., GUZMAN, J. and COSTABEL, U., 1999, Pentoxifylline inhibits TNF-ct production from human alveolar macrophages. American Journal of Respiratory and Critical Care Medicine, 159, 508–511.
  • METTLER, F. A. and GUSKOVA, A. K., 2001, Treatment of acute radiation sickness. In I. A. Gusev, A. K. Guskova and F. A. Mettler (eds), Medical Management of Radiation Accidents (Boca Raton: CRC Press), pp. 53–67.
  • METTLER, F. A. and VOELZ, G. L., 2002, Major radiation exposure—what to expect and how to respond. New England Journal of Medicine, 346, 1554–1561.
  • MIRALBELL, R., BIER', S., MERmirupD, B., HELG, C., SANCHO, G., PASTOORS, B., KELLER, A., KURTZ, J. M. and CHAPUIS, B., 1996, Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. Journal of Clinical Oncology, 14, 579–585.
  • MucHELL, J. B. and KRISHNA, M. C., 2002, Nitroxides as radiation protectors. Military Medicine, 167\(Suppl. 1), 49–50.
  • MOLTEN', A., MOULDER, J. E., COHEN, E. P., FISH, B. L., TAYLOR, J. M., VENO, P. A., WOLFE, L. F. and WARD, W. F., 2001, Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker. Experimental Biology and Medicine, 226, 1016–1023.
  • MOLTEN', A., MOULDER," E., COHEN, E. P., WARD, W. F., FISH, B. L., TAYLOR, J. M., WOLFE, L. F., BRIZIO-MOLTENI, L. and VENO, P., 2000, Control of radiation-induced pneumo-pathy and lung fibrosis by angiotensin converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. International Journal of Radiation Biology, 76, 523–532.
  • MOLTEN', A., WARD, W. F., TS'AO, C. H., TAYLOR, J., SMALL, W., BRIZIO-MOLTENI, L. and VENO, P. A., 2003, Cytostatic properties of some angiotensin II converting enzyme inhibitors and of angiotensin II type I receptor antagonists. Current Pharmaceutical Design, 9, 751–761.
  • MOULDER, J. E., 2002, Multiorgan problems associated with total and partial body irradiation. In R. C. Ricks, M. E. Berger and F. M. O'Hara (eds), The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims (Boca Raton: Parthenon), pp. 175–189.
  • MOULDER," E., 2003, Pharmacological intervention to prevent or ameliorate chronic radiation injuries. Seminars in Radiation Oncology, 13, 73–84.
  • MOULDER, J. E., I'm, B. L. and COHEN, E. P., 2003, ACE inhibitors and All receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy. Current Pharmaceutical Design, 9, 737–749.
  • MOULDER, J. E., FisH, B. L., REGNER, K. R. and Cori, E. P., 2002, Angiotensin II blockade reduces radiation-induced proliferation in experimental radiation nephropathy. Radiation Research, 157, 393–401.
  • MOULDER, J. E., ROBBINS, M. E. C., COHEN, E. P., HOPEWELL, J. W. and WARD, W. F., 1998, Pharmacologic modification of radiation-induced late normal tissue injury. Cancer Treatment and Research, 93, 129–151.
  • NATIONAL COUNCIL ON RADIATION PROTECTION AND MEASUREMENTS, 2001, Management of Terrorist Events Involving Radioactive Material. NCRP Report No. 138 (Bethesda: NCRPM).
  • NATIONAL RESEARCH COUNCIL, 2002, Making the Nation Safer: The Role of Science and Technology in Countering Terrorism (Washington, DC: National Academies Press).
  • OIKAWA, T., FREEMAN, M., Lo, W., VAUGHAN, D. E. and FOGO, A., 1997, Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin—angiotensin inhibition. Kidney International, 51, 164–172.
  • OLIVOTTO, I. A., KBA-SING, C., BAJDIK, C. D., TREVISAN, C. H., LUDGATE, C. M., WEIR, L. M., JACKSON, S. M. and BASCO, V. E., 1996, Effect of acetylsalicylic acid on radiation and cosmetic results after conservative surgery for early breast cancer: a randomized trial. Radiotherapy and Oncology, 41, 1–6.
  • OrrERsoN, M. F., SA, S. K. and MOULDER, J. E., 1996, The effects of radiation on gastrointestinal motility and potential therapies. In T. J. MacVittie, J. F. Weiss and D. Browne (eds), Advances in the Treatment of Radiation Injuries: Proceedings of the 2nd Consensus Development Conference on the Treatment of Radiation Injuries (New York: Pergamon), pp. 207–216.
  • PArupLE, N. and VOISIN, P., 1998, Is micronuclei yield variability a problem for overexposure dose assessment to ionizing radiation? Mutation Research—Genetic Toxicology and Environmental Mutagenesis, 413, 47–56.
  • PETER, R. U., 2002, Management of skin injuries in radiation accidents: the cutaneous radiation syndrome. In R. C. Ricks, M. E. Berger and F. M. O'Hara (eds), The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims (Boca Raton: Parthenon), pp. 225–229.
  • PoTrEN, C. S., 2002, Radiation injury of the gastrointestinal epithelium: current research on treatment, management, and prevention. In R. C. Ricks, M. E. Berger and F. M. O'Hara (eds), The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims (Boca Raton: Parthenon), pp. 139–148.
  • PRASANNA, P. G., ESCALADA, N. D. and BLAKELY, W. F., 2000, Induction of premature chromosome condensation by a phosphatase inhibitor and a protein kinase in unstimulated human peripheral blood lymphocytes: a simple and rapid technique to study chromosome aberrations using specific whole-chromosome DNA hybridization probes for biological dosimetry. Mutation Research, 466, 131–141.
  • REEVES, G. I., JARRETT, D. G., SEED, T. M., KING, G. L. and BLAKELY, W. F., 1998, Triage of Irradiated Personnel (Bethesda: Armed Forces Radiobiology Research Institute).
  • REZVANI, M., Mims, D. A., HODGES, H., HOPEWELL, J. W., MILLEHEw, K. and WILKINSON, J. H., 2001, Modification of radiation myelopathy by the transplantation of neural stem cells in the rat. Radiation Research, 156, 408–412.
  • RICKS, R. C., BERGER, M. E. and O'HARA, F. M., 2002, The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims (Boca Raton: Parthenon).
  • SORENSON, J. R. J., 2002, Cu, Fe, Mn, and Zn chelates offer a medicinal chemistry approach to overcoming radiation injury. Current Medicinal Chemistry, 9, 639–662.
  • STABEN, T., PORT, M., NUYKEN, I. and ABEND, M., 2003, Radiation-induced gene expression in MCF-7 cells. International Journal of Radiation Biology, 79, 319–331.
  • STONE, H. B., MCBRIDE, W. H. and COLEMAN, C. N., 2002, Modifying normal tissue damage postirradiation. Report of a workshop sponsored by the Radiation Protection Program, National Cancer Institute, Bethesda, Maryland, September 6-8, 2000. Radiation Research, 157, 204–223.
  • SUZUKI, Y., RUIZ-ORTEGA, M., LORENZO, 0., RUPEREZ, M., ESTEBAN, V. and EGIDO, J., 2003, Inflammation and angiotensin II. International Journal of Biochemistry and Cell Biology, 35, 881–900.
  • VAN DER MEEREN, A., MOUTHON, M. A" GAUGLER, M. fl" VANDAMIVIE, M. and GOURMELON, P., 2002, Administra-tion of recombinant human IL11 after supralethal radiation exposure promotes survival in mice: interac-tive effect with thrombopoietin. Radiation Research, 157, 642–649.
  • VUJASKOVIC, Z., BATINIC-HABERLE, I., RABBANI, Z. N., FENG, Q. F., KANG, S. K., SPASOJEVIC, I., SAMULSKI, T. V" FRIDOVICH, I., DEWITIRST, M. W. and ANSCHER, M. S., 2002, A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radical Biology and Medicine, 33, 857–863.
  • WANG, J. and HAUERJENSEN, M., 2003, Radiation toxicity and proteinase-activated receptors. Drug Development and Research, 60, 1–8.
  • WEISS, J. F. and LANDAUER, M. R., 2003, Protection against ionizing radiation by antioxidant nutrients and phyto-chemicals. Toxicology, 189, 1–20.
  • WfirrNALL, M. H., anoTr, T. B., HARDING, R. A., Ii, C. E., LANDAUER, M. R., WILHELMSEN, C. L., MCKINNEY, L., MINER, V. L., JACKSON, W. E., LoRIA, R. M., LEDNEY, G. D. and SEED, T. M., 2000, Androstenecliol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice. International Journal of Immuno-pharmacology, 22, 1–14.
  • WIERENGA, P. K., LIGHT, R., DE HAAN, G. and COPPES, R. P., 2002, Protection against radiation-induced damage to salivary glands by stem cell transplantation. Blood, 100, 158B–159B.
  • WINER-MURAM, H. T., GURNEY, J. W., BOZEMAN, P. M. and KRANcE, R. A., 1996, Pulmonary complications after bone marrow transplantation. Radiologic Clinics of North America, 34, 97–118.
  • ZDRAVKOVA, M., CROKART, N., TROMPIER, F., ASSELINEAU, B., GALLEZ, B., GAILLARD-LECANU, E. and DEBUYST, R., 2003, Retrospective dosimetry after criticality accidents using low-frequency EPR: a study of whole human teeth irradiated in a mixed neutron and gamma-radiation field. Radiation Research, 160, 168–173.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.